Tag: Ocugen Inc. (NASDAQ: OCGN)

Business

Ocugen Inc. (NASDAQ: OCGN), Provention Bio Inc. (NASDAQ: PRVB), Contextlogic Inc. (NASDAQ: WISH), and Acasti Pharma Inc. (NASDAQ: ACST) under probe For Securities Laws Violation

by 0 comments

Ocugen Inc. (NASDAQ: OCGN), Provention Bio Inc. (NASDAQ: PRVB), Contextlogic Inc. (NASDAQ: WISH), and Acasti Pharma Inc. (NASDAQ: ACST) are facing an investigation from various law firms on behalf of shareholders over potential securities laws violation.  Contextlogic under probe  Levi & Korsinsjy LLP is investigating Contextlogic on behalf of investors […]

Continue Reading →
Business

Ocugen Inc. (NASDAQ: OCGN) Will Not Submit EUA for COVAXIN as Indicated Earlier, Shares Plunge

by 0 comments

Ocugen Inc. (NASDAQ: OCGN) dropped 24% in intraday trading on June 14, 2021, after national shareholder rights litigation firm, The Schall Law Firm announced that it is probing securities laws violation claims on behalf of Ocugen investors.  Block & Leviton is also investigating the same matter, and investors that lost […]

Continue Reading →